| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Semnur Pharmaceuticals, Inc. (SMNR) has 1 insider with recent SEC Form 4 filings, including 2 buys and 2 sells. SMNR is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 181.80M | $1.08B | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 23, 2025 | Scilex Holding Co75 | 10% Owner | Sell | 12,500,000 | $16.00 | $200,000,000.00 | -6.4% | |
| Apr 11, 2022 | Xu Jiandong | 10% Owner | Buy | 510,000 | $10.00 | $5,100,000.00 | New | |
| Apr 11, 2022 | Denali Capital Global Investments LLC | 10% Owner | Buy | 510,000 | $10.00 | $5,100,000.00 | New |